← Back to Search

Endoscopy Device

PowerSpiral Enteroscopy System for Small Bowel Disease

N/A
Waitlist Available
Led By Daniel DeMarco, MD
Research Sponsored by Olympus Corporation of the Americas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intraoperative
Awards & highlights

Study Summary

The PowerSpiral Antegrade Investigational Device Exemption (IDE) Study

Eligible Conditions
  • Small Bowel Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intraoperative
This trial's timeline: 3 weeks for screening, Varies for treatment, and intraoperative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Maximum depth of endoscope insertion
Rate of device related serious adverse events
Secondary outcome measures
Adverse events
Device deficiencies
Diagnostic yield
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: PowerSpiral Enteroscopy SystemExperimental Treatment1 Intervention
Subjects who have a medical indication for antegrade enteroscopy

Find a Location

Who is running the clinical trial?

Olympus Corporation of the AmericasLead Sponsor
20 Previous Clinical Trials
2,115 Total Patients Enrolled
Baylor Research InstituteOTHER
200 Previous Clinical Trials
203,126 Total Patients Enrolled
University of Massachusetts, WorcesterOTHER
343 Previous Clinical Trials
986,510 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~37 spots leftby Apr 2025